Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Yearly assessment of bone disease in patients with smoldering myeloma identifies early bony progression events in 9.7% of patients with biochemical PD and could be considered a standard clinical practice.”
Authors: Ioannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, Despina Fotiou, Vasiliki Spiliopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios-Athanasios Dimopoulos, Lia-Angela Moulopoulos, Maria Gavriatopoulou et al.
More posts featuring Robert Orlowski.
